[1] 谢祯晖, 陈长源. 老年退行性心脏瓣膜病的流行病学现状及诊疗进展[J]. 国际心血管病杂志, 2023, 50(2): 65-68. [2] Aluru JS, Barsouk A, Saginala K, et al.Valvular Heart Disease Epidemiology[J]. Med Sci (Basel), 2022, 10(2): 32. [3] 张帅, 陆文远, 唐汉玮, 等. 中国合并心力衰竭的老年心脏瓣膜病患者的临床特征与外科治疗现状[J]. 中国循环杂志, 2023, 38(5): 520-525. [4] Eleid MF, Nkomo VT, Pislaru SV, et al.Valvular Heart Disease: New Concepts in Pathophysiology and Therapeutic Approaches[J]. Annu Rev Med, 2023, 74: 155-170. [5] Praz F, Beyersdorf F, Haugaa K, et al.Valvular heart disease: from mechanisms to management[J]. Lancet, 2024, 403(10436): 1576-1589. [6] Voss F, Sucker C, Litmathe J.[Anticoagulation after heart valve replacement][J]. Wien Med Wochenschr, 2023, 173(3-4): 84-89. [7] Sasaki K, Kunihara T, Suzuki S, et al.Multicenter Study of Surgical Ablation for Atrial Fibrillation in Aortic Valve Replacement[J]. ASAIO J, 2023, 69(5): 483-489. [8] Churyla A, Andrei A, Kruse J, et al.Safety of Atrial Fibrillation Ablation With Isolated Surgical Aortic Valve Replacement[J]. Ann Thorac Surg, 2021, 111(3): 809-817. [9] Czapka M, Moskal Ł, Rowiński A, et al.Comparison of postoperative complications following cardiac surgery with or without added surgical ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation[J]. Kardiol Pol, 2022, 80(6): 693-695. [10] Vahanian A, Beyersdorf F, Praz F, et al.2021 ESC/EACTS Guidelines for the management of valvular heart disease[J]. Eur Heart J, 2022, 43(7): 561-632. [11] Eleid MF, Nkomo VT, Pislaru SV, et al.Valvular Heart Disease: New Concepts in Pathophysiology and Therapeutic Approaches[J]. Annu Rev Med, 2023, 74: 155-170. [12] Kubala M, Chillou CD, Bohbot Y, et al.Arrhythmias in Patients With Valvular Heart Disease: Gaps in Knowledge and the Way Forward[J]. Front Cardiovasc Med, 2022, 9: 792559. [13] John B, Lau C.Atrial Fibrillation in Valvular Heart Disease[J]. Card Electrophysiol Clin, 2021, 13(1): 113-122. [14] Wasmer K, Eckardt L, Baumgartner H, et al.Therapy of supraventricular and ventricular arrhythmias in adults with congenital heart disease-narrative review[J]. Cardiovasc Diagn Ther, 2021, 11(2): 550-562. [15] Bennett RG, Garikapati K, Anderson RD, et al.Clinical, electroanatomic and electrophysiologic characterization and outcomes of catheter ablation for ventricular tachycardia following valvular intervention[J]. J Cardiovasc Electrophysiol, 2022, 33(4): 589-604. [16] Sasaki K, Kunihara T, Suzuki S, et al.Multicenter Study of Surgical Ablation for Atrial Fibrillation in Aortic Valve Replacement[J]. ASAIO J, 2023, 69(5): 483-489. [17] 韦柳炎, 焦国庆, 李明秋. 双房双极及单房单极射频消融术在心脏瓣膜病并发心房颤动患者中的临床应用对比观察[J]. 山东医药, 2021, 61(27): 74-76. [18] 白上林, 佘凯, 熊伟, 等. 房颤双极射频消融术在二尖瓣机械瓣膜置换患者中的应用效果分析[J]. 成都医学院学报, 2022, 17(3): 329-332. [19] Kowalewski M, Dąbrowski EJ, Kurasz A, et al. Surgical ablation of atrial fibrillation with concomitant cardiac surgery: a state-of-the-art review [J]. Eur J Cardiothorac Surg, 2025, 67(7): ezaf187. [20] 王海彦, 洪敏, 杜晓培, 等. 双极与单极射频消融术治疗心脏瓣膜病合并心房颤动的有效性和安全性对照研究[J]. 中西医结合心脑血管病杂志, 2023, 21(13): 2465-2469. [21] Nakajima K, Zweiker D, Spartalis M, et al.Bipolar Radiofrequency Catheter Ablation for Ventricular Arrhythmias[J]. Rev Cardiovasc Med, 2022, 23(5): 179. [22] Bella PD, Peretto G, Paglino G, et al.Bipolar radiofrequency ablation for ventricular tachycardias originating from the interventricular septum: Safety and efficacy in a pilot cohort study[J]. Heart Rhythm, 2020, 17(12): 2111-2118. [23] 周婷, 张松林. 迷宫Ⅳ型手术中对二尖瓣峡部线采取双极射频消融联合“切-缝”技术的安全性和疗效分析[J]. 中华胸心血管外科杂志, 2024, 40(6): 362-368. |